Management Change5 Nov 2026, 04:30 pm
Alkem Labs Appoints Dr. Amrut Naik as CEO
AI Summary
Alkem Laboratories Limited announced the appointment of Dr. Amrut Naik as the new Chief Executive Officer (CEO) and Key Managerial Personnel. The decision was made during a Board of Directors meeting held on November 3, 2026, following a recommendation from the Nomination and Remuneration Committee. Dr. Naik's appointment is effective from November 11, 2026. He brings over 26 years of global pharmaceutical business experience and holds a Ph.D. (Tech) in Pharmacology. The Board meeting commenced at 12:20 p.m. and concluded at 01:25 p.m. Further details are available on the company's website.
Key Highlights
- Dr. Amrut Naik appointed as CEO and KMP.
- Appointment effective from November 11, 2026.
- Dr. Naik has 26+ years of global pharma experience.
- Board meeting held on November 3, 2026.
Price Impact
More from ALKEM